Kymera Therapeutics KYMR Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's software and technology licenses, net?
- Kymera Therapeutics (KYMR) reported software and technology licenses, net of $7.7M in Q1 2026.
- How has Kymera Therapeutics's software and technology licenses, net changed year-over-year?
- Kymera Therapeutics's software and technology licenses, net increased by 132.3% year-over-year, from $3.31M to $7.7M.
- What is the long-term trend for Kymera Therapeutics's software and technology licenses, net?
- Over 5 years (2020 to 2025), Kymera Therapeutics's software and technology licenses, net has grown at a 213.7% compound annual growth rate (CAGR), from $30K to $9.11M.